SANOFI

In May 1956, Sanofi India or earlier known as Aventis Pharma (or APL) was being incorporated as Hoechst Fedco Pharma. Later the company name was changed to Hoechst Pharmaceuticals, Hoechst Marion Roussel, and Hoechst India. Also, the Sanofi-aventis is one of the world's leading pharmaceutical companies, and it is also the 100% subsidiary Hoechst GmbH that together holds up to 50.12% of its paid-up share capital. In India, the company operates via five entities such as Sanofi India Limited (earlier known as Aventis Pharma Limited), Sanofi Pasteur India Private Limited, Sanofi-Synthelabo (in India) Limited, Shantha Biotechnics Limited, and Genzyme India Private Limited. It also develops medicines in therapeutic areas such as thrombotic diseases, cardiovascular disease, metabolic disorders, and disorders of the central nervous system, oncology, internal medicine, and vaccines. Its product portfolio mainly consists of leading brands such as Cardace, Clexane, Daonil, Taxotere, Lantus, Soframycin, Arava, Combiflam, Lasix, and many more. Also, the manufacturing facilities are being located at Ankleshwar (in Gujarat) and Goa. The Company’s Ankleshwar unit has also received the certification of ISO 14001 for the Environment Management System. It also exports to countries such as Russia, the UK, Sri Lanka, and Egypt are among others.

The Business areas of the Company:

A world-class R&D pipeline is backing the Company, and Sanofi India has several leading positions in the several major therapeutic areas such as:

Central Nervous System
Oncology
Arthritis and Osteoporosis
Primary Health Care
Vaccines
Consumer Healthcare
Cardiovascular Diseases
Thrombosis
Diabetes
Internal Medicine

SANOFI Share Price Chart: Live